| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 58.123 | 79.672 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 58.156 | 79.697 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 14.472 | 29.137 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 43.684 | 50.560 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 43.114 | 48.456 |
| Employees | - | - | - | - | - | - | - | - | 1 | 1 |
Check the financial reports for the company - Levmed Diabet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 44.822 | 37.389 |
| Current Assets | - | - | - | - | - | - | - | - | 22.749 | 62.409 |
| Inventories | - | - | - | - | - | - | - | - | 0 | 21 |
| Receivables | - | - | - | - | - | - | - | - | 667 | 4.317 |
| Cash | - | - | - | - | - | - | - | - | 22.082 | 58.071 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 43.155 | 76.074 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 24.416 | 23.724 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Levmed Diabet S.r.l.